XML 29 R15.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Stockholders' Equity | 12 Months Ended
--- | ---
Dec. 29, 2017
Stockholders' Equity Note [Abstract] |
Stockholders’ Equity | Note 7: Stockholders’ Equity Preferred Stock The Company has authorized 2,000,000 shares of undesignated preferred stock with a par value of $0.001 per share. None of the preferred shares were issued and outstanding at December 29, 2017 and December 30, 2016. Dividends The Company declared and paid cash dividends per common share during the periods presented as follows:
|  | Fiscal Year 2017 |
|  | Dividends |  | Amount |
|  | Per Share |  | (in thousands) |
First Quarter |  | $ | 0.21 |  | $ | 5,374 |
Second Quarter |  | $ | 0.21 |  |  | 5,424 |
Third Quarter |  | $ | 0.21 |  |  | 5,424 |
Fourth Quarter |  | $ | 0.21 |  |  | 5,416 |
|  |  |  |  | $ | 21,638 |
|  | Fiscal Year 2016 |
|  | Dividends |  | Amount |
|  | Per Share |  | (in thousands) |
First Quarter |  | $ | 0.18 |  | $ | 4,628 |
Second Quarter |  | $ | 0.18 |  |  | 4,675 |
Third Quarter |  | $ | 0.18 |  |  | 4,659 |
Fourth Quarter |  | $ | 0.18 |  |  | 4,607 |
|  |  |  |  | $ | 18,569 |
On February 1, 2018 the Company’s Board of Directors announced a cash dividend of $0.26 per share of the Company’s common stock, payable March 23, 2018, to stockholders of record as of March 2, 2018. The Company expects to continue paying quarterly dividends in the future, subject to declaration by the Company’s Board of Directors. Treasury Stock Net losses related to the re-issuance of treasury stock to settle restricted stock unit and stock option awards of $5,667,000, $5,791,000 and $4,943,000 were recorded as a reduction to retained earnings during fiscal 2017, 2016 and 2015, respectively. Repurchase of Common Stock The Company repurchased 186,000 shares of its common stock for $11,931,000 during fiscal year 2017. The Company repurchased 491,000 shares of its common stock for $24,456,000 during fiscal year 2016. The Company repurchased 530,000 shares of its common stock for $23,314,000 during fiscal year 2015. On October 18, 2016 the Board of Directors authorized $35,000,000 for the repurchase of Exponent’s common stock. On October 20, 2015 the Board of Directors authorized $35,000,000 for the repurchase of Exponent’s common stock. On May 29, 2014 the Board of Directors authorized $35,000,000 for the repurchase of Exponent’s common stock. These repurchase programs have no expiration dates. As of December 29, 2017, the Company had remaining authorization under its stock repurchase plan of $45,376,000 to repurchase shares of common stock.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration